1 October 2025
SCCS preliminary opinion on Cannabidiol (CBD) used in cosmetic products.
SCCS preliminary opinion on Cannabidiol (CBD) used in cosmetic products.
On October 30th, 2025, the EU Scientific Committee on Consumer Safety (SCCS) adopted a preliminary opinion on the use of Cannabidiol in cosmetic products (SCCS/1685/25) establishing a maximum safe level for its use.
Scientific and Regulatory Background
Cannabidiol (CBD) is a naturally occurring cannabinoid found in Cannabis plants, although it can also be produced synthetically.
EU Member States and civil society organisations raised concerns about the limited safety information available for CBD in cosmetic products. In response, the European Commission mandated the SCCS to perform a safety assessment.
The impact of this preliminary opinion on CBD
Based on the submitted data, the SCCS has set maximum safe levels for CBD, and for delta-9-tetrahydrocannabinol (THC) when present as an impurity :
- CBD is considered safe up to 0.19% in dermal and oral cosmetic products
- THC impurities must not exceed 0.00025% (2.5 ppm) in dermal and oral cosmetic products
It is important to stress that this opinion does not cover products that may lead to inhalation exposure, so these safe levels do not apply to sprayable or aerosol formats, powders, pressurised sprays or any form that could generate inhalable particles. This mean that these products would be excluded from the regulation transposition and CBD would be forbidden in these products.
What is next?
The preliminary opinion is open for comments until January 21st, 2026. During this period, stakeholders may submit clarifications on the assessment, but no new data can be introduced. After the consultation closes, the SCCS will review the input, finalize its assessment and release the final opinion.
Under Article 31 of the Cosmetic Regulation, the European Commission may then amend the relevant Annexes if a potential health risk is identified or to reflect scientific and technical progress.
Biorius will continue monitoring all the developments related to this opinion and update this Information Letter accordingly if needed.
We hope that this page will be of help. Should you have any questions, please, feel free to contact your dedicated Customer Relationship Manager.
Your Biorius Team
Author
Christophe Brault-Chevalier
Christophe Brault-Chevalier is the Scientific & Regulatory Affairs Director at Biorius, bringing over 20 years of experience in the cosmetics industry. He has previously held positions at International Flavors & Fragrances Inc. (IFF) and LVMH, further enhancing his expertise in the field.
Related Posts
1 October 2025
Get in Touch
Need a piece of advice, a quotation or answers to your questions?
Fill in this form or contact us directly: info@biorius.com – We will answer as soon as possible!
As specialists in cosmetic Regulations for more than 15 years, Biorius offers a reliable turnkey solution for placing cosmeticproducts in various markets:
-
First Class specialists in cosmetic regulations in Europe, the United Kingdom, the United States, and in more than 60 countries -
50 regulatory experts, toxicologists, pharmacists, and chemists to serve you. -
A unique model that guarantees you both the fastest turnaround possible and high-quality services. Curious? Ask us to know more! -
A best-in-class IT tool, free of charge, and saving a lot of your time. -
More than 1,500 international clients have already chosen Biorius! -
We evaluated more than 100,000 products and have always successfully managed compliance over 15 years of existence
Get in Touch
"*" indicates required fields